May 11 (Reuters) - Numinus Wellness Inc NUMI.V :* NUMINUS WELLNESS AND OPTIMI HEALTH SUBMIT ALL-NATURAL PSILOCYBIN EXTRACT TO HEALTH CANADA FOR PRE-CLINICAL TRIAL APPLICATION
April 26 (Reuters) - Numinus Wellness Inc NUMI.V :* NUMINUS ANNOUNCES PHASE 1 CLINICAL TRIAL OF NATURAL PSILOCYBIN MUSHROOM EXTRACTION PREPARED AT COMPANY LAB* NUMINUS WELLNESS -...
March 15 (Reuters) - Numinus Wellness Inc NUMI.V :* NUMINUS WELLNESS INC. ANNOUNCES UPSIZED BOUGHT DEAL PUBLIC OFFERING TO $35 MILLION* NUMINUS WELLNESS - UNDERWRITERS HAVE...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 20.16 | 20.34 | 19.43 | +0.87 | +4.51% | 165.99K | Toronto | |||
| 3.73 | 3.75 | 3.71 | 0.000 | 0.00% | 12.19K | TSXV | |||
| 2.22 | 2.26 | 2.22 | +0.02 | +0.91% | 21.40K | TSXV | |||
| 1.10 | 1.14 | 1.07 | -0.03 | -2.65% | 1.60M | Toronto | |||
| 7.79 | 7.91 | 7.56 | +0.220 | +2.91% | 184.51K | Toronto | |||
| 4.72 | 4.87 | 4.64 | +0.020 | +0.43% | 141.15K | Toronto | |||
| 3.90 | 4.11 | 3.84 | +0.0400 | +1.04% | 67.14K | TSXV | |||
| 3.50 | 3.54 | 3.41 | +0.110 | +3.24% | 2.26M | Toronto | |||
| 0.18 | 0.00 | 0.00 | +0.0050 | +2.86% | 48.87K | TSXV | |||
| 0.17 | 0.00 | 0.00 | 0.0000 | 0.00% | 238.00K | CSE | |||
| 8.14 | 8.59 | 8.06 | -0.580 | -6.65% | 297.99K | Toronto | |||
| 2.12 | 2.12 | 2.04 | +0.050 | +2.42% | 4.12M | Toronto | |||
| 0.63 | 0.00 | 0.00 | +0.21 | +50.00% | 155.53K | Toronto | |||
| 16.59 | 17.41 | 16.49 | -0.780 | -4.49% | 1.12M | Toronto | |||
| 156.00 | 161.95 | 155.25 | -4.90 | -3.05% | 60.88K | Toronto |
Numinus Wellness Inc. (Numinus) is a Canada-based health care company focused on creating an ecosystem of wellness solutions through access, research, training and therapies centered on psychedelic therapies. The Company, through its subsidiary Salvation Botanicals Ltd, has a Health Canada cannabis testing license and dealer’s license. The testing license allows the Company to test and analyze cannabis products from licensed producers, and the dealer’s license allows the Company to test, possess, buy and sell methylenedioxymethamphetamine (MDMA), psilocybin, psilocin, dimethyltryptamine (DMT) and mescaline. Numinus also operates a stand-alone center offering patients integrative health solutions.